Woroniecka, K., & Fecci, P. E. (2020). 4-1BB Agonism as a strategy to license immune checkpoint blockade in glioblastoma. Oncoscience.
Chicago Style CitationWoroniecka, Karolina, i Peter E. Fecci. "4-1BB Agonism As a Strategy to License Immune Checkpoint Blockade in Glioblastoma." Oncoscience 2020.
Cita MLAWoroniecka, Karolina, i Peter E. Fecci. "4-1BB Agonism As a Strategy to License Immune Checkpoint Blockade in Glioblastoma." Oncoscience 2020.
Atenció: Aquestes cites poden no estar 100% correctes.